Evidence map›Paper›PMID 40341560›Full record

ArticleJNCI cancer spectrum2025

Leveraging geospatial data to support an implementation science approach to address lung cancer burden.

Tesla D DuBois, Alison C Brecher, Donna Edmondson, Evelyn Gonzalez, Charnita Zeigler-Johnson, Linda Fleisher, Shannon M Lynch

Abstract read
In one paragraph

Article in JNCI cancer spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tesla D DuBoisDivision of Cancer Prevention and Control, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA, United States.ORCID 0000-0001-5936-2493
Alison C BrecherDivision of Cancer Prevention and Control, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA, United States.ORCID 0000-0003-1391-0487
Donna EdmondsonDepartment of Medicine, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA, United States.
Evelyn GonzalezDivision of Cancer Prevention and Control, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA, United States.
Charnita Zeigler-JohnsonDivision of Cancer Prevention and Control, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA, United States.
Linda FleisherDivision of Cancer Prevention and Control, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA, United States.ORCID 0000-0002-6911-0756
Shannon M LynchDivision of Cancer Prevention and Control, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA, United States.ORCID 0000-0002-2066-9620

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Justine Yang Bruce · 1985 to 2026
$142.6M
Training Grant in Precision Cancer ControlT32CA278766 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Carolyn Y. Fang · 2023 to 2026
$950k
Cancer Center Cessation Initiative 5P30CA014520-50Fox Chase Cancer CenterNCINCI NIH HHS P30 CA014520NCI NIH HHS T32 CA278766
6 · The paper itself

Abstract

The lung cancer mortality rate in Philadelphia is 16% higher than the national rate, making screening and prevention efforts paramount. To support prevention efforts, Fox Chase Cancer Center operates a comprehensive tobacco treatment program that employs an implementation science approach and provides more than 1000 individuals with various therapeutic strategies to support smoking cessation. Using the tobacco treatment program as a case study, this brief report describes the adaptation of the Reach, Effectiveness, Adoption, Implementation, and Maintenance framework into a geospatial format. Each dimension of the geospatial Reach, Effectiveness, Adoption, Implementation, and Maintenance framework results in a map that can help identify (1) target areas for intervention (Reach), (2) the degree to which the program is serving those areas (Effectiveness), (3) opportunities for partnership to support delivery (Adoption), (4) contextual factors influencing how the intervention is best delivered (Implementation), and (5) strategies for long-term integration of the intervention (Maintenance). This framework supports targeted, sustainable initiatives.

Indexed as

Implementation ScienceLung NeoplasmsSmoking CessationHumansPhiladelphiaProgram Evaluation

Identifiers

PMID40341560
PMCPMC12132098

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.